Mechanical Methods for the Induction of Labour After Previous Caesarean Section - An Updated, Evidence-based Review.
balloon catheter
hygroscopic cervical dilators
induction of labour after Caesarean section
prostaglandins
uterine rupture
Journal
Geburtshilfe und Frauenheilkunde
ISSN: 0016-5751
Titre abrégé: Geburtshilfe Frauenheilkd
Pays: Germany
ID NLM: 0370732
Informations de publication
Date de publication:
Jul 2022
Jul 2022
Historique:
received:
06
12
2021
accepted:
29
12
2021
entrez:
11
7
2022
pubmed:
12
7
2022
medline:
12
7
2022
Statut:
epublish
Résumé
There are currently no up-to-date evidence-based recommendations on the preferred method to induce labour after previous Caesarean section, especially for patients with unripe cervix, as randomised controlled studies are lacking. Intravenous oxytocin and misoprostol are contraindicated in these women because of the high risk of uterine rupture. In women with ripe cervix (Bishop Score > 6), intravenous administration of oxytocin is an effective procedure with comparable rates of uterine rupture to those with spontaneous onset of labour. Vaginal prostaglandin E
Identifiants
pubmed: 35815098
doi: 10.1055/a-1731-7441
pmc: PMC9262630
doi:
Types de publication
Journal Article
Langues
eng
Pagination
727-735Informations de copyright
The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/).
Déclaration de conflit d'intérêts
Conflict of Interest Patrick Stelzl has a part-time job agreement as consultant and speaker and is member of the Steering Committee in concerns of the LION (“Labour Induction Outcomes Network”) project for Angusta 25 µg tablets from Norgine Pharma GmbH. / Patrick Stelzl hat eine werksvertraglich geregelte nebenberufliche Berater- und Referenten-Tätigkeit und ist Steering Committee Mitglied im Rahmen des LION („Labour Induction Outcomes Network“) Projektes für das Einleitungs-Präparat Angusta 25 µg Tabletten von der Firma Norgine Pharma GmbH.
Références
J Gynecol Obstet Hum Reprod. 2018 Dec;47(10):539-543
pubmed: 30253940
J Perinatol. 2017 Jul;37(7):787-792
pubmed: 28406484
Arch Gynecol Obstet. 2015 Feb;291(2):273-80
pubmed: 25178187
J Matern Fetal Neonatal Med. 2016 Oct;29(20):3286-91
pubmed: 26699657
PLoS One. 2018 Jul 2;13(7):e0200024
pubmed: 29965989
Obstet Gynecol. 2010 Aug;116(2 Pt 1):450-463
pubmed: 20664418
BMC Pregnancy Childbirth. 2021 Jan 6;21(1):11
pubmed: 33407241
Am J Obstet Gynecol. 2012 Jan;206(1):51.e1-5
pubmed: 22000899
Taiwan J Obstet Gynecol. 2018 Jun;57(3):421-426
pubmed: 29880177
Am J Obstet Gynecol. 2017 Feb;216(2):165.e1-165.e8
pubmed: 27780708
Gynecol Obstet Fertil Senol. 2019 Mar;47(3):273-280
pubmed: 30745158
Geburtshilfe Frauenheilkd. 2021 Aug;81(8):870-895
pubmed: 34393254
Geburtshilfe Frauenheilkd. 2021 Jan;81(1):70-80
pubmed: 33487667
Eur J Obstet Gynecol Reprod Biol. 2016 Sep;204:44-50
pubmed: 27521597
Eur J Obstet Gynecol Reprod Biol. 2017 Nov;218:73-84
pubmed: 28963922
N Engl J Med. 2001 Jul 5;345(1):3-8
pubmed: 11439945
Acta Obstet Gynecol Scand. 2020 Feb;99(2):259-266
pubmed: 31432510
J Reprod Med. 2002 Jul;47(7):549-54
pubmed: 12170531
Am J Obstet Gynecol. 2000 Nov;183(5):1176-9
pubmed: 11084562
J Matern Fetal Neonatal Med. 2017 May;30(9):1010-1015
pubmed: 27265361
Swiss Med Wkly. 2017 Nov 09;147:w14532
pubmed: 29120029
Semin Perinatol. 2015 Oct;39(6):444-9
pubmed: 26341067
Int J Gynaecol Obstet. 2018 Sep;142(3):288-294
pubmed: 29893994
Eur J Obstet Gynecol Reprod Biol. 2013 Sep;170(1):25-32
pubmed: 23810846
J Gynecol Obstet Biol Reprod (Paris). 2016 May;45(5):496-501
pubmed: 26123014
J Perinat Med. 2021 Aug 02;49(7):797-805
pubmed: 34333894
BMJ Open. 2019 Nov 6;9(11):e028896
pubmed: 31699720
Obstet Gynecol. 2007 Feb;109(2 Pt 1):262-9
pubmed: 17267822
Acta Obstet Gynecol Scand. 2019 Jul;98(7):920-928
pubmed: 30723900
J Perinat Med. 2018 Apr 25;46(3):299-307
pubmed: 28672756
Arch Gynecol Obstet. 2020 Apr;301(4):931-940
pubmed: 32140810
Obstet Gynecol Surv. 2012 Nov;67(11):734-45
pubmed: 23151757
Semin Perinatol. 2016 Aug;40(5):281-6
pubmed: 27210023
Cochrane Database Syst Rev. 2019 Oct 18;10:CD001233
pubmed: 31623014
Cochrane Database Syst Rev. 2017 Jun 09;6:CD009792
pubmed: 28599068
J Gynecol Obstet Hum Reprod. 2018 Mar;47(3):127-131
pubmed: 29229362
Evid Rep Technol Assess (Full Rep). 2010 Mar;(191):1-397
pubmed: 20629481
Am J Perinatol. 2019 Dec;36(14):1431-1436
pubmed: 31146296
PLoS One. 2021 Jul 6;16(7):e0253957
pubmed: 34228760
Eur J Obstet Gynecol Reprod Biol X. 2019 May 01;4:100033
pubmed: 31673685
BJOG. 2004 Dec;111(12):1394-9
pubmed: 15663125
Arch Gynecol Obstet. 2017 May;295(5):1135-1143
pubmed: 28315935
Geburtshilfe Frauenheilkd. 2015 Nov;75(11):1140-1147
pubmed: 26719597
Obstet Gynecol. 2015 Sep;126(3):539-551
pubmed: 26244535